Clinical Trial Update: Quantitative Mass Transfer of SFP-iron From Dialysate to Blood in CKD-HD Patients [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/Phase 2 trial update on quantitative mass transfer of SFP-iron from dialysate into the blood of dialysis-dependent kidney failure patients, with results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• End-stage Renal Disease

Drugs mentioned

• SFP-iron (sodium ferric pyrophosphate)

Snippet

Sponsor: Rockwell Medical Technologies, Inc. | Conditions: Kidney Failure | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2015-01-09